Skip to main content
Erschienen in: Techniques in Coloproctology 2/2020

01.02.2020 | Original Article

Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases

verfasst von: Oliver Peacock, Peadar S. Waters, Joseph C. Kong, Satish K. Warrier, Chris Wakeman, Tim Eglinton, Declan G. Murphy, Alexander G. Heriot, Frank A. Frizelle, Jacob J. McCormick

Erschienen in: Techniques in Coloproctology | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Extensive multi-visceral resection, including components of the urinary tract, is often required to achieve clear resection margins, which is now well established as a key predictor of long-term survival for locally advanced pelvic tumours. The aims of this study were to analyse major morbidity and factors predicting complications and long-term outcomes following a urological procedure within extended radical resections.

Methods

Data were collected from prospective databases at two high-volume institutions specialising in extended radical resections for locally advanced and recurrent pelvic malignancies between 1990 and 2015. The primary endpoints were general major complications (Clavien–Dindo ≥ 3) and factors influencing complications and overall survival after urological resection.

Results

A total of 646 consecutive patients requiring an extended radical resection for locally advanced or recurrent pelvic malignancies were identified. The median age was 63 years (range 19–89 years) and the majority were female (371; 57.4%). A urological resection was performed as part of the resection in 226 patients (35.0%). The overall 30-day major complication rate was significantly higher in the urological intervention group (23%; n = 52) compared to the non-urological group (12.9%; n = 54 patients; p = 0.001). Intestinal anastomotic leak (p = 0.001) and intra-abdominal collections (p = 0.001) were more common in the urological cohort. Ileal conduit formation was an independent predictor of major morbidity (OR 1.95; 95% CI 1.24–3.07; p = 0.004). Independent prognostic markers for poor 5-year survival following urological procedures were recurrent tumour, cardiovascular disease, previous thromboembolic event and postoperative pulmonary embolism.

Conclusions

Extended radical resections which include a urological resection are associated with significantly more major morbidity than those without urological resection. Ileal conduit formation is independently associated with the development of major morbidity. Five-year overall survival is no different for patients who had or did not have urological resection as part of extended radical surgery for locally advanced or recurrent pelvic malignancy.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Beyond TME Consensus (2013) Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg 100:1009–1014CrossRef Beyond TME Consensus (2013) Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg 100:1009–1014CrossRef
2.
Zurück zum Zitat Harris CA, Solomon MJ, Heriot AG et al (2016) The outcomes and patterns of treatment failure after surgery for locally recurrent rectal cancer. Ann Surg 264:323–329CrossRef Harris CA, Solomon MJ, Heriot AG et al (2016) The outcomes and patterns of treatment failure after surgery for locally recurrent rectal cancer. Ann Surg 264:323–329CrossRef
3.
Zurück zum Zitat Pawlik TM, Skibber JM, Rodriguez-Bigas MA (2006) Pelvic exenteration for advanced pelvic malignancies. Ann Surg Oncol 13:612–623CrossRef Pawlik TM, Skibber JM, Rodriguez-Bigas MA (2006) Pelvic exenteration for advanced pelvic malignancies. Ann Surg Oncol 13:612–623CrossRef
4.
Zurück zum Zitat Bhangu A, Ali SM, Darzi A, Brown G, Tekkis P (2012) Meta-analysis of survival based on resection margin status following surgery for recurrent rectal cancer. Colorectal Dis 14:1457–1466CrossRef Bhangu A, Ali SM, Darzi A, Brown G, Tekkis P (2012) Meta-analysis of survival based on resection margin status following surgery for recurrent rectal cancer. Colorectal Dis 14:1457–1466CrossRef
5.
Zurück zum Zitat PelvEx Collaboration (2019) Surgical and survival outcomes following pelvic exenteration for locally advanced primary rectal cancer: results from an international collaboration. Ann Surg 269:315–321CrossRef PelvEx Collaboration (2019) Surgical and survival outcomes following pelvic exenteration for locally advanced primary rectal cancer: results from an international collaboration. Ann Surg 269:315–321CrossRef
6.
Zurück zum Zitat Teixeira SC, Ferenschild FT, Solomon MJ et al (2012) Urological leaks after pelvic exenterations comparing formation of colonic and ileal conduits. Eur J Surg Oncol 38:361–366CrossRef Teixeira SC, Ferenschild FT, Solomon MJ et al (2012) Urological leaks after pelvic exenterations comparing formation of colonic and ileal conduits. Eur J Surg Oncol 38:361–366CrossRef
7.
Zurück zum Zitat Houvenaeghel G, Moutardier V, Karsenty G et al (2004) Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients. Gynecol Oncol 92:680–683CrossRef Houvenaeghel G, Moutardier V, Karsenty G et al (2004) Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients. Gynecol Oncol 92:680–683CrossRef
8.
Zurück zum Zitat Bhangu A, Ali SM, Brown G, Nicholls RJ, Tekkis P (2014) Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer. Ann Surg 259:315–322CrossRef Bhangu A, Ali SM, Brown G, Nicholls RJ, Tekkis P (2014) Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer. Ann Surg 259:315–322CrossRef
9.
Zurück zum Zitat Brown KG, Solomon MJ, Latif ER et al (2017) Urological complications after cystectomy as part of pelvic exenteration are higher than that after cystectomy for primary bladder malignancy. J Surg Oncol 115:307–311CrossRef Brown KG, Solomon MJ, Latif ER et al (2017) Urological complications after cystectomy as part of pelvic exenteration are higher than that after cystectomy for primary bladder malignancy. J Surg Oncol 115:307–311CrossRef
10.
Zurück zum Zitat van den Heijkant F, Vermeer TA, Vrijhof E, Nieuwenhuijzen GAP, Koldewijn EL, Rutten HJT (2017) Psoas hitch ureteral reimplantation after surgery for locally advanced and locally recurrent colorectal cancer: Complications and oncological outcome. Eur J Surg Oncol 43:1869–1875CrossRef van den Heijkant F, Vermeer TA, Vrijhof E, Nieuwenhuijzen GAP, Koldewijn EL, Rutten HJT (2017) Psoas hitch ureteral reimplantation after surgery for locally advanced and locally recurrent colorectal cancer: Complications and oncological outcome. Eur J Surg Oncol 43:1869–1875CrossRef
11.
Zurück zum Zitat Stotland PK, Moozar K, Cardella JA et al (2009) Urologic complications of composite resection following combined modality treatment of colorectal cancer. Ann Surg Oncol 16:2759–2764CrossRef Stotland PK, Moozar K, Cardella JA et al (2009) Urologic complications of composite resection following combined modality treatment of colorectal cancer. Ann Surg Oncol 16:2759–2764CrossRef
12.
Zurück zum Zitat Brown KG, Koh CE, Vasilaras A, Eisinger D, Solomon MJ (2014) Clinical algorithms for the diagnosis and management of urological leaks following pelvic exenteration. Eur J Surg Oncol 40:775–781CrossRef Brown KG, Koh CE, Vasilaras A, Eisinger D, Solomon MJ (2014) Clinical algorithms for the diagnosis and management of urological leaks following pelvic exenteration. Eur J Surg Oncol 40:775–781CrossRef
13.
Zurück zum Zitat Heriot AG, Byrne CM, Lee P et al (2008) Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum 51:284–291CrossRef Heriot AG, Byrne CM, Lee P et al (2008) Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum 51:284–291CrossRef
14.
Zurück zum Zitat Davis NF, Burke JP, McDermott T, Flynn R, Manecksha RP, Thornhill JA (2015) Bricker versus Wallace anastomosis: a meta-analysis of ureteroenteric stricture rates after ileal conduit urinary diversion. Can Urol Assoc J 9:E284–290CrossRef Davis NF, Burke JP, McDermott T, Flynn R, Manecksha RP, Thornhill JA (2015) Bricker versus Wallace anastomosis: a meta-analysis of ureteroenteric stricture rates after ileal conduit urinary diversion. Can Urol Assoc J 9:E284–290CrossRef
15.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRef Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRef
16.
Zurück zum Zitat Berrios-Torres SI, Umscheid CA, Bratzler DW et al (2017) Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg 152:784–791CrossRef Berrios-Torres SI, Umscheid CA, Bratzler DW et al (2017) Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg 152:784–791CrossRef
17.
Zurück zum Zitat Rahbari NN, Weitz J, Hohenberger W et al (2010) Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery 147:339–351CrossRef Rahbari NN, Weitz J, Hohenberger W et al (2010) Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery 147:339–351CrossRef
18.
Zurück zum Zitat Wagenlehner FM, Pilatz A, Naber KG, Weidner W (2008) Therapeutic challenges of urosepsis. Eur J Clin Invest 38(Suppl 2):45–49CrossRef Wagenlehner FM, Pilatz A, Naber KG, Weidner W (2008) Therapeutic challenges of urosepsis. Eur J Clin Invest 38(Suppl 2):45–49CrossRef
20.
Zurück zum Zitat Turner GA, Harris CA, Eglinton TW et al (2016) Cystoprostatectomy versus prostatectomy alone for locally advanced or recurrent pelvic cancer. ANZ J Surg 86:54–58CrossRef Turner GA, Harris CA, Eglinton TW et al (2016) Cystoprostatectomy versus prostatectomy alone for locally advanced or recurrent pelvic cancer. ANZ J Surg 86:54–58CrossRef
21.
Zurück zum Zitat Goldberg GL, Sukumvanich P, Einstein MH, Smith HO, Anderson PS, Fields AL (2006) Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987–2003). Gynecol Oncol 101:261–268CrossRef Goldberg GL, Sukumvanich P, Einstein MH, Smith HO, Anderson PS, Fields AL (2006) Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987–2003). Gynecol Oncol 101:261–268CrossRef
22.
Zurück zum Zitat Lopez MJ, Standiford SB, Skibba JL (1994) Total pelvic exenteration. A 50-year experience at the Ellis Fischel Cancer Center. Arch Surg 129:390–395CrossRef Lopez MJ, Standiford SB, Skibba JL (1994) Total pelvic exenteration. A 50-year experience at the Ellis Fischel Cancer Center. Arch Surg 129:390–395CrossRef
23.
Zurück zum Zitat Brunschwig A (1948) Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer 1:177–183CrossRef Brunschwig A (1948) Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer 1:177–183CrossRef
24.
Zurück zum Zitat Bolmstrand B, Nilsson PJ, Holm T, Buchli C, Palmer G (2018) Patterns of complications following urinary tract reconstruction after multivisceral surgery in colorectal and anal cancer. Eur J Surg Oncol 44:1513–1517CrossRef Bolmstrand B, Nilsson PJ, Holm T, Buchli C, Palmer G (2018) Patterns of complications following urinary tract reconstruction after multivisceral surgery in colorectal and anal cancer. Eur J Surg Oncol 44:1513–1517CrossRef
25.
Zurück zum Zitat Bochner BH, Sjoberg DD, Laudone VP, Memorial Sloan Kettering Cancer Center Bladder Cancer Surgical Trials G (2014) A randomized trial of robot-assisted laparoscopic radical cystectomy. N Engl J Med 371:389–390CrossRef Bochner BH, Sjoberg DD, Laudone VP, Memorial Sloan Kettering Cancer Center Bladder Cancer Surgical Trials G (2014) A randomized trial of robot-assisted laparoscopic radical cystectomy. N Engl J Med 371:389–390CrossRef
26.
Zurück zum Zitat Tortorella L, Casarin J, Mara KC et al (2019) Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies. Gynecol Oncol 152:151–156CrossRef Tortorella L, Casarin J, Mara KC et al (2019) Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies. Gynecol Oncol 152:151–156CrossRef
27.
Zurück zum Zitat Hsu TW, Chiang FF, Chen MC, Wang HM (2011) Pelvic exenteration for men with locally advanced rectal cancer: a morbidity analysis of complicated cases. Asian J Surg 34:115–120CrossRef Hsu TW, Chiang FF, Chen MC, Wang HM (2011) Pelvic exenteration for men with locally advanced rectal cancer: a morbidity analysis of complicated cases. Asian J Surg 34:115–120CrossRef
28.
Zurück zum Zitat Kusters M, Austin KK, Solomon MJ, Lee PJ, Nieuwenhuijzen GA, Rutten HJ (2015) Survival after pelvic exenteration for T4 rectal cancer. Br J Surg 102:125–131CrossRef Kusters M, Austin KK, Solomon MJ, Lee PJ, Nieuwenhuijzen GA, Rutten HJ (2015) Survival after pelvic exenteration for T4 rectal cancer. Br J Surg 102:125–131CrossRef
29.
Zurück zum Zitat Aslim EJ, Chew MH, Chew GK, Lee LS (2018) Urological outcomes following pelvic exenteration for advanced pelvic cancer are not inferior to those following radical cystectomy. ANZ J Surg 88:896–900CrossRef Aslim EJ, Chew MH, Chew GK, Lee LS (2018) Urological outcomes following pelvic exenteration for advanced pelvic cancer are not inferior to those following radical cystectomy. ANZ J Surg 88:896–900CrossRef
30.
Zurück zum Zitat Somani BK, Gimlin D, Fayers P, N'Dow J (2009) Quality of life and body image for bladder cancer patients undergoing radical cystectomy and urinary diversion–a prospective cohort study with a systematic review of literature. Urology 74:1138–1143CrossRef Somani BK, Gimlin D, Fayers P, N'Dow J (2009) Quality of life and body image for bladder cancer patients undergoing radical cystectomy and urinary diversion–a prospective cohort study with a systematic review of literature. Urology 74:1138–1143CrossRef
31.
Zurück zum Zitat Russo P, Ravindran B, Katz J, Paty P, Guillem J, Cohen AM (1999) Urinary diversion after total pelvic exenteration for rectal cancer. Ann Surg Oncol 6:732–738CrossRef Russo P, Ravindran B, Katz J, Paty P, Guillem J, Cohen AM (1999) Urinary diversion after total pelvic exenteration for rectal cancer. Ann Surg Oncol 6:732–738CrossRef
32.
Zurück zum Zitat Aoyama T, Oba K, Honda M et al (2017) Impact of postoperative complications on the colorectal cancer survival and recurrence: analyses of pooled individual patients' data from three large phase III randomized trials. Cancer Med 6:1573–1580CrossRef Aoyama T, Oba K, Honda M et al (2017) Impact of postoperative complications on the colorectal cancer survival and recurrence: analyses of pooled individual patients' data from three large phase III randomized trials. Cancer Med 6:1573–1580CrossRef
33.
Zurück zum Zitat Klok FA, Zondag W, Kralingen KWV et al (2010) Patient outcomes after acute pulmonary embolism. Am J Respir Crit Care Med 181:501–506CrossRef Klok FA, Zondag W, Kralingen KWV et al (2010) Patient outcomes after acute pulmonary embolism. Am J Respir Crit Care Med 181:501–506CrossRef
34.
Zurück zum Zitat White MC, Holman DM, Boehm JE, Peipins LA, Grossman M, Henley SJ (2014) Age and cancer risk: a potentially modifiable relationship. Am J Prev Med 46:S7–15CrossRef White MC, Holman DM, Boehm JE, Peipins LA, Grossman M, Henley SJ (2014) Age and cancer risk: a potentially modifiable relationship. Am J Prev Med 46:S7–15CrossRef
35.
Zurück zum Zitat Janssen-Heijnen ML, Houterman S, Lemmens VE, Louwman MW, Maas HA, Coebergh JW (2005) Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol 55:231–240CrossRef Janssen-Heijnen ML, Houterman S, Lemmens VE, Louwman MW, Maas HA, Coebergh JW (2005) Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol 55:231–240CrossRef
36.
Zurück zum Zitat Kong CH, Guest GD, Stupart DA, Faragher IG, Chan ST, Watters DA (2015) Colorectal preoperative surgical score (CROSS) for mortality in major colorectal surgery. ANZ J Surg 85:403–407CrossRef Kong CH, Guest GD, Stupart DA, Faragher IG, Chan ST, Watters DA (2015) Colorectal preoperative surgical score (CROSS) for mortality in major colorectal surgery. ANZ J Surg 85:403–407CrossRef
37.
Zurück zum Zitat Janssen-Heijnen ML, Szerencsi K, van de Schans SA, Maas HA, Widdershoven JW, Coebergh JW (2010) Cancer patients with cardiovascular disease have survival rates comparable to cancer patients within the age-cohort of 10 years older without cardiovascular morbidity. Crit Rev Oncol Hematol 76:196–207CrossRef Janssen-Heijnen ML, Szerencsi K, van de Schans SA, Maas HA, Widdershoven JW, Coebergh JW (2010) Cancer patients with cardiovascular disease have survival rates comparable to cancer patients within the age-cohort of 10 years older without cardiovascular morbidity. Crit Rev Oncol Hematol 76:196–207CrossRef
Metadaten
Titel
Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases
verfasst von
Oliver Peacock
Peadar S. Waters
Joseph C. Kong
Satish K. Warrier
Chris Wakeman
Tim Eglinton
Declan G. Murphy
Alexander G. Heriot
Frank A. Frizelle
Jacob J. McCormick
Publikationsdatum
01.02.2020
Verlag
Springer International Publishing
Erschienen in
Techniques in Coloproctology / Ausgabe 2/2020
Print ISSN: 1123-6337
Elektronische ISSN: 1128-045X
DOI
https://doi.org/10.1007/s10151-019-02141-4

Weitere Artikel der Ausgabe 2/2020

Techniques in Coloproctology 2/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.